• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身弥散加权背景抑制成像(DWIBS)在疑似头颈部癌症患者分期中的临床价值。

Clinical Value of Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS) for Staging of Patients with Suspected Head and Neck Cancer.

机构信息

Department of Radiology, University Medical Center Regensburg, 93053 Regensburg, Germany.

Department of Othorhinolaryngology, Merciful Brothers Hospital St. Elisabeth, 94315 Straubing, Germany.

出版信息

Tomography. 2022 Oct 9;8(5):2522-2532. doi: 10.3390/tomography8050210.

DOI:10.3390/tomography8050210
PMID:36287809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9607011/
Abstract

(1) Background: To determine the importance of diffusion-weighted whole-body MRI with background body signal suppression (DWIBS) in the staging process of patients with suspected head and neck carcinomas. (2) Methods: A total of 30 patients (24 male, 6 female) with a median age of 67 years with clinically suspected head and neck carcinoma with pathologic cervical nodal swelling in ultrasound underwent the staging procedure with computed tomography (CT) and whole-body MRI including DWIBS. (3) Results: In a total of 9 patients, abnormalities in the routine work-up of pretherapeutic staging were found. Five cases of either secondary cancer or distant metastases were only visible in DWIBS, while being missed on CT. One diagnosis was only detectable in CT and not in DWIBS, whereas three diagnoses were recognizable in both modalities. (4) Conclusions: DWIBS in addition to a standard neck MRI in cervical lymphadenopathy suspicious for head and neck cancer yielded additional clinically relevant diagnoses in 17% of cases that would have been missed by current staging routine procedures. DWIBS offered a negative predictive value of 98.78% for ruling out distant metastases or secondary malignancies.

摘要

(1) 背景:确定背景抑制弥散加权全身 MRI(DWIBS)在疑似头颈部癌患者分期过程中的重要性。(2) 方法:共 30 例(24 例男性,6 例女性)患者,中位年龄 67 岁,临床怀疑头颈部癌,超声检查发现颈部淋巴结病理性肿大,行 CT 和全身 MRI 检查,包括 DWIBS。(3) 结果:在总共 9 例患者中,在治疗前分期的常规检查中发现了异常。5 例继发性癌症或远处转移仅在 DWIBS 中可见,而在 CT 上漏诊。1 例诊断仅在 CT 上可见,而在 DWIBS 上不可见,而 3 例诊断在两种方式下均可见。(4) 结论:在疑似头颈部癌的颈部淋巴结病患者中,DWIBS 联合标准颈部 MRI 检查可在 17%的病例中提供额外的临床相关诊断,这些诊断会被当前的分期常规检查遗漏。DWIBS 对排除远处转移或继发性恶性肿瘤的阴性预测值为 98.78%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/aa2913b52996/tomography-08-00210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/6054b6bc145f/tomography-08-00210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/5ebb4c43037b/tomography-08-00210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/223b824d56ea/tomography-08-00210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/9af7b3a401b2/tomography-08-00210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/aa2913b52996/tomography-08-00210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/6054b6bc145f/tomography-08-00210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/5ebb4c43037b/tomography-08-00210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/223b824d56ea/tomography-08-00210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/9af7b3a401b2/tomography-08-00210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9088/9607011/aa2913b52996/tomography-08-00210-g005.jpg

相似文献

1
Clinical Value of Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS) for Staging of Patients with Suspected Head and Neck Cancer.全身弥散加权背景抑制成像(DWIBS)在疑似头颈部癌症患者分期中的临床价值。
Tomography. 2022 Oct 9;8(5):2522-2532. doi: 10.3390/tomography8050210.
2
Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.全身磁共振成像包括弥散加权体部成像在头颈部鳞状细胞癌患者检查中的应用:一项可行性研究
Eur J Radiol. 2014 Jul;83(7):1144-1151. doi: 10.1016/j.ejrad.2014.03.019. Epub 2014 Mar 30.
3
Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.背景体部信号抑制扩散加权全身成像(DWIBS)技术对全身磁共振成像在检测甲状腺癌骨转移中的补充价值。
J Med Imaging Radiat Oncol. 2013 Jun;57(3):297-305. doi: 10.1111/1754-9485.12020. Epub 2012 Dec 28.
4
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.非小细胞肺癌的术前分期:全身扩散加权磁共振成像与 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的比较。
Eur Radiol. 2012 Dec;22(12):2859-67. doi: 10.1007/s00330-012-2542-y. Epub 2012 Jul 9.
5
Diagnostic performance of F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-FDG PET/CT)及背景体部抑制全身扩散加权成像(DWIBS)在检测小儿神经母细胞瘤淋巴结及骨转移中的诊断效能
Ann Nucl Med. 2018 Jun;32(5):348-362. doi: 10.1007/s12149-018-1254-z. Epub 2018 Apr 17.
6
Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.采用全身扩散加权成像和 T2 加权 MRI 评估惰性非侵袭性淋巴瘤:30 例患者前瞻性研究结果。
Cancer Imaging. 2021 Jan 7;21(1):5. doi: 10.1186/s40644-020-00371-6.
7
Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.正电子发射断层扫描与磁共振弥散加权成像(DWIBS)联合体部抑脂技术在恶性淋巴瘤分期中的对比研究。
Eur J Radiol. 2013 Nov;82(11):2011-7. doi: 10.1016/j.ejrad.2013.05.042. Epub 2013 Aug 9.
8
Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.3.0T全身扩散加权磁共振成像在原发性和转移性肿瘤检测中的诊断准确性
J Med Imaging Radiat Oncol. 2013 Jun;57(3):274-82. doi: 10.1111/1754-9485.12026. Epub 2013 Jan 7.
9
Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.全身 MRI 弥散加权成像联合三维对比增强 T1 加权成像在肿瘤分期中的作用:与 PET-CT 的比较。
Eur J Radiol. 2012 Aug;81(8):1917-25. doi: 10.1016/j.ejrad.2011.08.005. Epub 2011 Sep 9.
10
Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer.弥散加权全身成像(DWIBS)联合背景抑制技术对肺癌转移或复发的检测具有有效性和经济性。
Thorac Cancer. 2021 Mar;12(5):676-684. doi: 10.1111/1759-7714.13820. Epub 2021 Jan 21.

引用本文的文献

1
Visualizing Aortic Inflammation by Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS).通过背景体部信号抑制的扩散加权全身成像(DWIBS)可视化主动脉炎症。
Diagnostics (Basel). 2025 Apr 30;15(9):1151. doi: 10.3390/diagnostics15091151.
2
Diagnostic Value of Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) for the Pre-Therapeutic Loco-Regional Staging of Cervical Cancer: A Feasibility and Interobserver Reliability Study.背景抑制弥散加权成像(DWIBS)对宫颈癌术前局部区域分期的诊断价值:一项可行性和观察者间可靠性研究。
Curr Oncol. 2023 Jan 13;30(1):1164-1173. doi: 10.3390/curroncol30010089.
3

本文引用的文献

1
[Whole-body MRI in cancer predisposition syndromes].[癌症易感综合征中的全身磁共振成像]
Radiologie (Heidelb). 2022 Dec;62(12):1017-1025. doi: 10.1007/s00117-022-01067-7. Epub 2022 Sep 13.
2
Diffusion-weighted imaging with background body signal suppression (DWIBS) distinguishes benign lesions from malignant pulmonary solitary lesions.背景体部信号抑制扩散加权成像(DWIBS)可区分肺部孤立性良性病变与恶性病变。
Am J Transl Res. 2021 Jan 15;13(1):88-101. eCollection 2021.
3
Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer.
Additional Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) Improves Pre-Therapeutical Detection of Early-Stage (pT1a) Glottic Cancer: A Feasibility and Interobserver Reliability Study.
背景体部信号抑制的附加扩散加权成像(DWIBS)改善早期(pT1a)声门癌的治疗前检测:一项可行性和观察者间可靠性研究
Diagnostics (Basel). 2022 Dec 16;12(12):3200. doi: 10.3390/diagnostics12123200.
弥散加权全身成像(DWIBS)联合背景抑制技术对肺癌转移或复发的检测具有有效性和经济性。
Thorac Cancer. 2021 Mar;12(5):676-684. doi: 10.1111/1759-7714.13820. Epub 2021 Jan 21.
4
Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.原发灶不明的转移性宫颈淋巴结鳞状细胞癌:人乳头瘤病毒时代的管理
Front Oncol. 2020 Nov 10;10:593164. doi: 10.3389/fonc.2020.593164. eCollection 2020.
5
Comparative Study between F FDG-PET/CT and Whole Body MRI DWIBS in Assessment of Recurrent Breast Cancer (Prospective, Comparative, Cross-sectional Study Design).18F-FDG-PET/CT与全身MRI扩散加权体部成像在复发性乳腺癌评估中的对比研究(前瞻性、对比性、横断面研究设计)
Indian J Nucl Med. 2019 Jan-Mar;34(1):1-9. doi: 10.4103/ijnm.IJNM_121_18.
6
Comparison of the seventh and eighth edition american joint committee on cancer oral cavity staging systems.美国癌症联合委员会第七版与第八版口腔癌分期系统的比较。
Laryngoscope. 2018 Oct;128(10):2351-2360. doi: 10.1002/lary.27205. Epub 2018 Apr 15.
7
Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity.扩散加权体部成像/ T2图像融合与正电子发射断层显像/计算机断层扫描在腹腔癌症诊断中的比较
Exp Ther Med. 2017 Oct;14(4):3754-3760. doi: 10.3892/etm.2017.4987. Epub 2017 Aug 22.
8
Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.全身磁共振成像包括弥散加权体部成像在头颈部鳞状细胞癌患者检查中的应用:一项可行性研究
Eur J Radiol. 2014 Jul;83(7):1144-1151. doi: 10.1016/j.ejrad.2014.03.019. Epub 2014 Mar 30.
9
¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.¹⁸F-FDG PET/CT 和 3.0-T 全身 MRI 用于检测未经治疗的口咽/下咽癌患者的远处转移和第二原发肿瘤:一项比较研究。
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1607-19. doi: 10.1007/s00259-011-1824-y. Epub 2011 May 13.
10
Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla.头颈部鳞状细胞癌的功能成像:PET/CT 与 3T 磁共振弥散加权成像的相关性。
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1009-19. doi: 10.1007/s00259-010-1718-4. Epub 2011 Apr 5.